TBC Bank Group PLC (LON:TBCG)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions GEL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	666.65	1,284	1,124	995.21	800.78	317.75
Depreciation & Amortization	75.57	145.29	116.33	101.2	79.89	68.39
Change in Other Net Operating Assets	-5,612	-4,934	-3,303	-2,484	-2,607	-1,350
Other Operating Activities	1,108	-18.97	202.36	6.98	167.5	18.33
Operating Cash Flow	-3,762	-3,524	-1,860	-1,381	-1,559	-945.83
Capital Expenditures	-313.71	-340.24	-263.24	-226.4	-163.22	-164.38
Sale of Property, Plant and Equipment	2.79	1.34	4.67	17.45	20.83	3.63
Cash Acquisitions	-	-	-	-	-17.22	-
Investment in Securities	-1,021	-2,025	-366.76	-1,199	619.21	-565.42
Divestitures	-	-	-	-	57.04	-
Other Investing Activities	0.63	0.68	0.7	-	-	0.69
Investing Cash Flow	-1,323	-2,352	-617.41	-1,403	540.27	-711.97
Long-Term Debt Issued	-	6,079	2,362	2,666	2,046	4,142
Long-Term Debt Repaid	-	-2,793	-1,847	-1,968	-3,364	-3,337
Net Debt Issued (Repaid)	2,607	3,287	514.55	697.21	-1,318	804.17
Repurchase of Common Stock	-51.44	-70.66	-58.99	-65.11	-	-25.49
Common Dividends Paid	-275.02	-275.02	-279.25	-238.98	-81.77	-1.34
Net Increase (Decrease) in Deposit Accounts	2,678	2,098	2,333	4,883	2,605	1,432
Other Financing Activities	29.56	42.63	-93.57	39.83	-5.95	-
Financing Cash Flow	4,988	5,081	2,416	5,316	1,200	2,209
Foreign Exchange Rate Adjustments	-43.43	77.81	-34.63	-394.23	-94.66	80.24
Net Cash Flow	-139.53	-716.69	-96.73	2,139	86.73	631.82
Free Cash Flow	-4,075	-3,864	-2,123	-1,607	-1,722	-1,110
Free Cash Flow Margin	-146.55%	-147.21%	-96.74%	-82.84%	-116.39%	-138.69%
Free Cash Flow Per Share	-73.03	-70.04	-38.87	-28.84	-30.83	-20.11
Cash Interest Paid	992.99	1,821	1,363	1,088	867.21	839.26
Cash Income Tax Paid	191.55	355.57	184.12	243.79	13.76	46.27

Source: S&P Global Market Intelligence. Banks template. Financial Sources.